Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium

被引:84
作者
Prow, Tarl W.
Bhutto, Imran
Kim, Sahng Y.
Grebe, Rhonda
Merges, Carol
McLeod, D. Scott
Uno, Koichi
Mennon, Mohamed
Rodriguez, Li [2 ]
Leong, Kam [3 ]
Lutty, Gerard A. [1 ]
机构
[1] Johns Hopkins Univ, Wilmer Ophthalmol Inst, Sch Med, Baltimore, MD 21287 USA
[2] US FDA, Rockville, MD 20857 USA
[3] Duke Univ, Durham, NC USA
关键词
Chitosan; Magnetic nanoparticle; Gene delivery; Retina; Toxicity;
D O I
10.1016/j.nano.2008.06.003
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Chitosan, PCEP (poly{[(cholesteryl oxocarbonylamido ethyl) methyl bis(ethylene) ammonium iodide] ethyl phosphate}), and magnetic nanoparticles (MNPs) were evaluated for the safe delivery of genes in the eye. Rabbits were injected with nanoparticles either intravitreally (IV) or subretinally (SR) and sacrificed 7 days later. Eyes were grossly evaluated for retinal pigment epithelium abnormalities, retinal degeneration, and inflammation. All eyes were cryopreserved and sectioned for analysis of toxicity and expression of either enhanced green or red fluorescent proteins. All of the nanoparticles were able to transfect cells in vitro and in vivo. IV chitosan showed inflammation in 12/13 eyes, whereas IV PCEP and IV MNPs were not inflammatory and did not induce retinal pathology. SR PCEP was nontoxic in the majority of cases but yielded poor transfection, whereas SR MNPs were nontoxic and yielded good transfection. Therefore, we conclude that the best nanoparticle evaluated in vivo was the least toxic nanoparticle tested, the MNP. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:340 / 349
页数:10
相关论文
共 17 条
  • [1] Localization of collagen XVIII and the endostatin portion of collagen XVIII in aged human control eyes and eyes with age-related macular degeneration
    Bhutto, IA
    Kim, SY
    McLeod, DS
    Merges, C
    Fukai, N
    Olsen, BR
    Lutty, GA
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (05) : 1544 - 1552
  • [2] Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells
    Dang, JM
    Sun, DDN
    Shin-Ya, Y
    Sieber, AN
    Kostuik, JP
    Leong, KW
    [J]. BIOMATERIALS, 2006, 27 (03) : 406 - 418
  • [3] Chitosan nanoparticles as a potential drug delivery system for the ocular surface:: Toxicity, uptake mechanism and in vivo tolerance
    de Salamanca, AE
    Diebold, Y
    Calonge, M
    García-Vazquez, C
    Callejo, S
    Vila, A
    Alonso, MJ
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2006, 47 (04) : 1416 - 1425
  • [4] Chitosan-g-PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions
    Jiang, X
    Dai, H
    Leong, KW
    Goh, SH
    Mao, HQ
    Yang, YY
    [J]. JOURNAL OF GENE MEDICINE, 2006, 8 (04) : 477 - 487
  • [5] Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery
    Lee, Dongwon
    Zhang, Weidong
    Shirley, Shawna A.
    Kong, Xiaoyuan
    Hellermann, Gary R.
    Lockey, Richard F.
    Mohapatra, Shyam S.
    [J]. PHARMACEUTICAL RESEARCH, 2007, 24 (01) : 157 - 167
  • [6] DNA-polycation nanospheres as non-viral gene delivery vehicles
    Leong, KW
    Mao, HQ
    Truong-Le, VL
    Roy, K
    Walsh, SM
    August, JT
    [J]. JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) : 183 - 193
  • [7] LUTTY GA, 1993, INVEST OPHTH VIS SCI, V34, P477
  • [8] Bevacizumab for neovascular ocular diseases
    Lynch, Shalini S.
    Cheng, Christine M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2007, 41 (04) : 614 - 625
  • [9] Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
    Mao, HQ
    Roy, K
    Troung-Le, VL
    Janes, KA
    Lin, KY
    Wang, Y
    August, JT
    Leong, KW
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) : 399 - 421
  • [10] Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases
    Ng, Eugene W. M.
    Adamis, Anthony P.
    [J]. OLIGONUCLEOTIDE THERAPEUTICS, 2006, 1082 : 151 - 171